Recruiting

Biobank

Sponsor:

University of Kansas Medical Center

Code:

NCT05392881

Conditions

Interstitial Lung Disease

Sarcoidosis

Idiopathic Pulmonary Fibrosis

Pulmonary Fibrosis

Hypersensitivity Pneumonitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

Establish a interstitial lung disease (ILD) registry and biorepository to lead towards a further understanding of the disease.

Conditions

Interstitial Lung Disease

Sarcoidosis

Idiopathic Pulmonary Fibrosis

Pulmonary Fibrosis

Hypersensitivity Pneumonitis

Study ID

NCT05392881

Start date

Aug 9, 2021

Status verified date

Jul, 2026

Completion date

Mar 1, 2032

Anticipated

Primary completion date

Aug 1, 2031

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. The participant is a patient at TUKHS or has agreed to participate in a study approved by the KUMC Human Research Protection Program (HRPP)
2. The participant is being followed for the presence of autoimmune disease, ILD or other rare lung diseases at TUKHS.
3. The participant is ≥ 18 years of age.
4. The participant has signed an approved consent for this study (living patients only)

Study Design

Enrollment

1000 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Collect clinically obtained data for patients with ILD, RLD and risk for ILD/RLD to support research. [ Time Frame: Enrollment to Year 10 ]
  • Establish a collection of biological samples from patients with ILD, RLD and subjects at risk for ILD. [ Time Frame: Enrollment to Year 10 ]
  • Correlate biological samples with individual longitudinal clinical data. [ Time Frame: Enrollment to Year 10 ]
  • Provide biological samples to researchers performing studies in ILD and RLD. [ Time Frame: Enrollment to Year 10 ]
  • Collect historical data and imaging from deceased patients with ILD. [ Time Frame: Enrollment to Year 10 ]

Central Contacts and Locations

Central contacts

Kimberly Donnelly, Ph.D.

913-588-6067kdonnelly@kumc.edu

Locations

The University of Kansas Medical Center

Recruiting

Kansas City, Kansas, United States, 66160

Contacts

Kimberly Donnelly, Ph.D.

913-588-6067kdonnelly@kumc.edu

Principal Investigator:

Chase Hall, M.D.

More Information

Sponsor

University of Kansas Medical Center

Last update posted

Jul 10, 2026

Last verified

Jul, 2026

Keywords

  • Interstitial Lung Disease
  • Sarcoidosis
  • Idiopathic Pulmonary Fibrosis
  • Pulmonary Fibrosis
  • Hypersensitivity Pneumonitis

Trial information was received from ClinicalTrials.gov and was last updated on 2026-10-02. This information was provided to ClinicalTrials.gov by University of Kansas Medical Center on 2026-07-10. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.